Merck – Commonplaces

Ebola – Small Market for Vaccines

October 26, 2022 by sergneri 1 Comment

From the 10/26/2022 PROMED Digest email, in an entry on the current Ugandan Sudan Ebola outbreak, is this snippet from a longer release. It seems “a long, tortured history” is an apt description of the efforts for an ebola vaccine. Small market ———— Ebola vaccines have a long, tortured history. The VSV platform used … [Read more…]

Molnupiravir and Paxlovid – The New COVID Drugs

November 29, 2021 by sergneri Leave a Comment

In the Atlantic, Dr. Monica Gandhi writes about The New COVID Drugs Although molnupiravir—which is named after the Norse god Thor’s hammer, Mjölnir—was being tested for the treatment of the Ebola virus, researchers had not settled upon a purpose for the drug before SARS-CoV-2 arrived on the scene. Early studies of molnupiravir showed that its … [Read more…]